Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,107,336
-$23,387,350 QoQ
Shares Held
6,784,927
+15.8% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. NUVB ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,107,336 | 6,784,927 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $52,494,686 | 5,858,782 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $22,529,984 | 6,089,185 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,840,018 | 5,558,984 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,546,588 | 4,856,016 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,235,981 | 4,599,993 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,541,149 | 4,166,441 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,608,197 | 3,975,410 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,078,376 | 3,043,510 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,623,943 | 3,062,214 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,059,054 | 3,029,145 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,438,602 | 3,021,446 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,637,055 | 2,793,407 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,102,807 | 2,657,712 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $6,877,691 | 3,070,398 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $9,551,889 | 2,948,114 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $15,763,415 | 2,996,847 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $23,239,306 | 2,734,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,947,171 | 1,403,136 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,569,901 | 920,505 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $444,125 | 42,500 | Shares | Defined | 2021-07-09 | |
| No filing history on record for this holder in this stock. | ||||||